Highlights:
- The ASX 200 Health Care sector closed strong yesterday.
- Sectoral influence along with an upbeat current healthcare market have driven CSL’s share price up on the ASX.
- CSL Limited shares ended higher too.
Australian healthcare giant CSL Limited (ASX:CSL) ended yesterday's session tad strong. CSL’s shares closed at AU$295.240 per share, up 1.376%.
The S&P/ASX 200 Health Care sector (INDEXASX:XHJ) closed at 43,005.40, up 1.62%.
What impacted CSL’s share price on the ASX:
Australian biotechnology company CSL did not come up with any price-sensitive announcement on the ASX.
The S&P/ASX 200 index (INDEXASX:XJO) closed up and 7 out of 11 sectors closed higher.
ASX 200 Health Care sector was one of the best performing sectors that closed in green. The index ended 1.62% higher, prompting major sectoral stocks to end on robust note.
The company’s last announcement was an update on its proposed Vifor Pharma acquisition. In the announcement on 12 May 2022, the company announced that its acquisition of Vifor had been delayed due to some regulatory approvals.
Overview of CSL’s share price performance on the ASX:
CSL’s share price gained 2.07% in last one year, shed 0.25 on Y-T-D basis and gained 12.44% in last six months.